Posts Tagged ‘Injury’

KTM Off-Road Motorcycle Recall

Tuesday, February 2nd, 2010

KTM, maker of the defective off road motorcycle, conducted a voluntarily RECALL OF THE 2009 OFF ROAD MOTORCYCLES, in cooperation with The Consumer Product and Safety Commission. The recall was initiated because of the undue risk for injury or death from the motorcycle’s front fork failure. Consumers are advised to immediately stop using the off road motorcycle.

The KTM recall involves approximately 550 2009 Off Road Motorcycle models in orange and black, including: 125SX, 150SX, 250XC-W, and 300XC-W. The defective models were manufactured in Austria and sold in the U.S. from December of 2008 through April 2009. The hazard that has been identified is associated with the front fork inner tube. The front fork inner tube may crack and dislodge from the fork axle. The breakage of the inner tube poses a risk of injury or death to the driver or people surrounding the driver at the time of the breakage. The off road motorcycle costs between $6000. and $8000. Consumers are advised to immediately stop using the off road motorcycle, contact KTM at (888) 985-6090 for a free repair, or visit the KTM North America Inc., of Amherst, Ohio website.

VN:F [1.5.6_840]
Rating: 0.0/10 (0 votes cast)
VN:F [1.5.6_840]
Rating: 0 (from 0 votes)

Ethex Recall: Over-Dose Tablets Pose Risks

Thursday, May 21st, 2009

By Lesley Ranft

Ethex Corporation announced multiple recalls of numerous drugs, including morphine, iron and prenatal vitamins. The string of recalls began to commence last year due to double dose tablets of morphine and other potential concerns. There have been recent reports that the FDA is questioning adequate quality control at the manufacturing facility where the morphine tablets were made. As Richard Schulte, Attorney at Law of Dayton, Ohio explains, “This is a clear case of manufacturer defect. The problem we are faced with now is we do not yet know the extent of defective pills on the market and how great of harm they caused to consumers.”

Signs of Overdose
The long term effects of the prenatal vitamins are unknown. Iron supplement overdose side effects usually occur shortly after intake. Iron poisoning side effects may include, vomiting diarrhea, liver dysfunction, jaundice, internal bleeding, and seizures.-1- The initial signs of overdose in morphine are clear and can be life threatening, but may not be fully apparent to the person using the drug. Opioid overdose includes:
• Rapid Heart Beat
• Hypertension
• Tremors
• Bluish Lips
• Headache
• Insomnia
• Dizziness and Fainting
• Blurred vision
• Upset stomach
• Fainting
• Low Blood Pressure

The List of Ethex Recalls

Isosorbide mononitrate: 30mg and 60mg
Propafenone HCI: 150mg, 225mg, and 300 mg
Dextroamphetamine sulfate tablets: 5mg and 10mg
Morphine sulfate ER: 15mg, 30mg, 60mg, 100mg 200mg
Morphine IR: 15mg and 30mg

Prenatal Vitamin Recalls
Advanced NatalCare® Tablets and Advanced-RF NatalCare® Tablets
Cal-Nate™ Tablets
CareNatal™ DHA Tablets
ComBgen Tablets
ComBiRx™Tablets
NataCaps Capsules
NatalCare Gloss, PIC, PIC Forte, Plus, Rx, Three Tablets
NataTab FA Tablets
NataTab RX Tablets
NutriNate® Chewable Tablets
NutriSpire™ Tablets
Prenatal MR 90 FE and MTR w/Selinium Tablets
Prenatal Rx 1 Tablets
Prenatal Z, Advanced Formula Tablets
Ultra NatalCare Tablets

Iron Supplement Recalls
Anemagen Caplets
Anemagen Forte Caplets
Conison™ Capsules
Fe-Tinic™ 150 Forte Capsules

-1- http://www.merck.com/mmhe/sec24/ch297/ch297h.html

VN:F [1.5.6_840]
Rating: 0.0/10 (0 votes cast)
VN:F [1.5.6_840]
Rating: 0 (from 0 votes)

Bridgestone Motorcycle Tire Recall Update

Monday, May 18th, 2009

In April 2009, The National Highway Traffic Safety Administration (NHTSA) reported that Bridgestone Americas Tire Operation (BATO) recalled select Bridgestone Exedra G850 G motorcycle tires, size 180/70R16 77H. These motorcycle tires were originally sold for 2008 and 2009 Triumph Rocket III Touring motorcycle models.

The defect of the tires relates to the risk of torque-induced degradation in the body ply which may result in the inner lining cracking and a leak in the rear tire. The tires may vibrate at low to moderate speeds. The defect creates a risk of injury or death to the driver and individuals surrounding the vehicle. Consumers are advised to immediately stop using the affected tires, contact Bridgestone for a free replacement of both front and rear tires at (800) 465-1904. The recall commenced in April 2009.

VN:F [1.5.6_840]
Rating: 0.0/10 (0 votes cast)
VN:F [1.5.6_840]
Rating: 0 (from 0 votes)

Welch Allyn Automated Defibrillators AED Recalled (May 2009)

Thursday, May 14th, 2009

Video originally created by FDA -- posted by Lawsuit.com on May 8th, 2009

The device company Welch Allyn is recalling about 14,000 automated external defibrillators. The affected models are AED 10 and MRL JumpStart defibrillators manufactured between October 3, 2002 and January 25, 2007.

A number of problems have been reported with these defibrillators. They include devices that deliver less defibrillation energy than they were programmed for, susceptibility to electromagnetic interference, and unexpected shutdown during use. These problems could prevent a patient in cardiac arrest from being defibrillated, which could be fatal.

The company has sent a letter to its customers about the recall, giving them instructions to return their units without delay so they may be repaired or replaced.

Customers in the U.S. and Canada may either exchange their AED 10 for a similar device at no cost, or purchase a new AED 10 directly from Welch Allyn at a reduced cost. International customers will be offered exchange AED 10 devices.

For more information, contact the company at 1-888-345-5356.

VN:F [1.5.6_840]
Rating: 0.0/10 (0 votes cast)
VN:F [1.5.6_840]
Rating: 0 (from 0 votes)

Depakote Warning: Children Have Lower IQ’s

Wednesday, May 13th, 2009

Study results published in the New England Journal of Medicine have demonstrated that depakote, aka Valproate, used during pregnancy may result in the child having a lower IQ. Depakote has also been associated with a high rate of fetal death and birth defects such as spina bifida in children of mothers who used Depakote. The study was performed by Dr. Kimford Meador of Emory University and a team of researchers.

Depakote is used to treat epileptic seizures, mood disorders and migraine headaches. The study followed pregnant women in the U.S. and England that had taken anti-seizure medications between 1999 and 2004.The study compared the IQ scores of children by 3 years of age whose mothers had taken one of four types of anti-seizure medications, including: depakote, lamotrigine (also known as lemectal), phenytoin, and carbamazepine. The study results showed that Depakote children ranked six to nine points lower on the IQ scale when compared to children whose mothers took other anti-seizure medications. The average IQ for a “Depokote child” was 92. The IQ ranges of the other children were between 98 and 101. The average rating for a child’s intelligence is 100. The study results also demonstrated that the higher the dosage that the “Depakote mother” received, the lower the IQ the child had. Dosage levels were irrelevant in the other anti-seizure medications.

In 2007, Meader study results presented at the American Academy of Neurology showed a marked risk for retardation in children whose mothers had taken Depakote. This rate of risk was twice as great as the risk associated with other anti-seizure medications. Twenty four percent of the children who mother took depakote and participated in Meador’s study had an IQ level that is associated with retardation.

According to the Alliance for Human Resource Protection, approximately 25,000 U.S. children are born to women who have epilepsy annually. It is important to note that just because the other anti-seizure medications are not associated with an elevated risk for lower IQ’ed children, does not mean that there are not other types of risks for injury. For example, there have been reports that lemectal is associated with Steven’s Johnson Syndrome, a life threatening and severely debilitating condition.

VN:F [1.5.6_840]
Rating: 0.0/10 (0 votes cast)
VN:F [1.5.6_840]
Rating: 0 (from 0 votes)